DrugsControl Media Services

News Detail

Glenmark recalls 114 batches of low potassium drug in the US over potentially deadly hyperkalemia risk (27-06-2024)

MAHWAH, N.J. , 27 JUNE 2024: While patients with low potassium often need medication to boost levels of the electrolyte in the body, too much of a good thing can cause serious health concerns.

View Details

Source : Fierce Pharma
Glenmark Pharmaceuticals hyperkalemia drug manufacturing drug safety side effects U.S. FDA drug recall voluntary recall Fierce Pharma Homepage Manufacturing Pharma

Related News